Stock Earnings

Question 1

Ginkgo Bioworks Holdings Incの主要な財務諸表は何ですか？

Accepted Answer

最新の財務諸表（Form-10K）によると、Ginkgo Bioworks Holdings Incの総資産は$1,377で、純lossは$-547です。

Question 2

DNAの主要な財務比率は何ですか？

Accepted Answer

Ginkgo Bioworks Holdings Incの流動比率は2.08、純利益率は-240.96、1株当たり売上高は$4.37です。

Question 3

Ginkgo Bioworks Holdings Incの収益はセグメントまたは地域別にどのように分けられていますか？

Accepted Answer

Currently Ginkgo Bioworks Holdings Inc data is not available.

Question 4

Ginkgo Bioworks Holdings Incは収益を上げていますか？

Accepted Answer

no、最新の財務諸表によると、Ginkgo Bioworks Holdings Incの純lossは$-547です。

Question 5

Ginkgo Bioworks Holdings Incに負債はありますか？

Accepted Answer

yes、Ginkgo Bioworks Holdings Incの負債は661です。

Question 6

Ginkgo Bioworks Holdings Incの発行済株式数は何株ですか？

Accepted Answer

Ginkgo Bioworks Holdings Incの総発行済株式数は54.36株です。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	230	227	251	477	313	76
Revenue Growth (YoY)	25%	-10%	-47%	52%	312%	41%
Cost of Revenue	48	44	54	204	129	15
Gross Profit	182	182	197	273	184	61
Selling, General & Admin	208	241	192	1,383	863	38
Research & Development	277	424	580	1,052	1,149	159
Operating Expenses	486	665	773	2,436	2,012	198
Other Non Operating Income (Expenses)	13	28	14	132	80	16
Pretax Income	-316	-547	-892	-2,121	-1,838	-124
Income Tax Expense	0	0	0	-15	-1	1
Net Income	-315	-547	-892	-2,104	-1,830	-126
Net Income Growth	-65%	-39%	-57.99%	15%	1,352%	6%
Shares Outstanding (Diluted)	54.85	51.89	48.61	1,679.1	1,359.8	1,874.8
Shares Change (YoY)	7%	7%	-97%	23%	-27%	0%
EPS (Diluted)	-5.74	-10.54	-18.36	-1.25	-1.35	-0.07
EPS Growth	-67%	-43%	1,369%	-7%	1,829%	17%
Free Cash Flow	-274	-382	-336	-304	-310	-193
Free Cash Flow Per Share	-4.99	-7.36	-6.91	-0.18	-0.22	-0.1
Gross Margin	79.13%	80.17%	78.48%	57.23%	58.78%	80.26%
Operating Margin	-132.17%	-212.77%	-229.48%	-453.24%	-584.02%	-180.26%
Profit Margin	-136.95%	-240.96%	-355.37%	-441.09%	-584.66%	-165.78%
Free Cash Flow Margin	-119.13%	-168.28%	-133.86%	-63.73%	-99.04%	-253.94%
EBITDA	-241	-420	-506	-2,120	-1,799	-124
EBITDA Margin	-104.78%	-185.02%	-201.59%	-444.44%	-574.76%	-163.15%
D&A For EBITDA	63	63	70	42	29	13
EBIT	-304	-483	-576	-2,162	-1,828	-137
EBIT Margin	-132.17%	-212.77%	-229.48%	-453.24%	-584.02%	-180.26%
Effective Tax Rate	0%	0%	0%	0.7%	0.05%	-0.8%

Ginkgo Bioworks Holdings Inc (DNA) Price